soluble guanylate cyclase activators (Merck & Co)

N/A

Report date: 2025/01/26 17:05:51
NME

Base Information

Drug Namesoluble guanylate cyclase activators (Merck & Co)
Drug Alias NameMRL-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGuanylate cyclase stimulants
TargetsGuanylate cyclase
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A